Abstract
We describe an experimental setup and a currently running experiment for evaluating how physical interactions over time and between individuals affect the spread of epidemics. Our experiment involves the voluntary use of the Safe Blues Android app by participants at The University of Auckland (UoA) City Campus in New Zealand. The app spreads multiple virtual safe virus strands via Bluetooth depending on the social and physical proximity of the subjects. The evolution of the virtual epidemics is recorded as they spread through the population. The data is presented as a real-time (and historical) dashboard. A simulation model is applied to calibrate strand parameters. Participants’ locations are not recorded, but participants are rewarded based on the duration of participation within a geofenced area, and aggregate participation numbers serve as part of the data. Once the experiment is complete, the data will be made available as an open-source anonymized dataset.
This paper outlines the experimental setup, software, subject-recruitment practices, ethical considerations, and dataset description. The paper also highlights current experimental results in view of the lockdown that started in New Zealand at 23:59 on August 17, 2021. The experiment was initially planned in the New Zealand environment, expected to be free of COVID and lockdowns after 2020. However, a COVID Delta strain lockdown shuffled the cards and the experiment is currently extended into 2022.
Author summary In this paper, we describe the Safe Blues Android app experimental setup and a currently running experiment at the University of Auckland City Campus. This experiment is designed to evaluate how physical interactions over time and between individuals affect the spread of epidemics.
The Safe Blues app spreads multiple virtual safe virus strands via Bluetooth based on the subjects’ unobserved social and physical proximity. The app does not record the participants’ locations, but participants are rewarded based on the duration of participation within a geofenced area, and aggregate participation numbers serve as part of the data. When the experiment is finished, the data will be released as an open-source anonymized dataset.
The experimental setup, software, subject recruitment practices, ethical considerations, and dataset description are all described in this paper. In addition, we present our current experimental results in view of the lockdown that started in New Zealand at 23:59 on August 17, 2021. The information we provide here may be useful to other teams planning similar experiments in the future.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
A.A. is supported by the ARC Centre of Excellence for Mathematical and Statistical Frontiers (ACEMS) and UoA Faculty of Science Research & Development Fund (FRDF). S.G.H. is supported by National Science Foundation grant CMMI 2035086. Y.N. is supported by the Australian Research Council (ARC) under grant no. DP180101602 and UQ Research Support Package: Strategic Research Investment. A.S. is supported by the UQ Research Support Package: Strategic Research Investment. K.R.S is supported by NHMRC investigator grant 2007919 P.G.T. is supported by the ARC Centre of Excellence for Mathematical and Statistical Frontiers (ACEMS) under grant no. CE140100049. I.Z. is supported by Te Pūnaha Matatini.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Te Komiti mō ngā Tāngata Whai Pānga Matatika o te Whare Wānanga o Tāmaki Makaurau University of Auckland Human Participants Ethics Committee (UAHPEC) - Ref. number: UAHPEC22143
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
At the conclusion of the experiment, data will be made available via https://safeblues.org/data
Data Availability
At the conclusion of the experiment, data will be made available via https://safeblues.org/data
